Lifecare AS Net Assets
Lifecare AS net assets. Based on the latest financial reports, Lifecare AS (LIFE) has net assets worth Nkr54.47 Million NOK (≈ $5.73 Million USD) as of June 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Nkr62.95 Million ≈ $6.62 Million USD) and total liabilities (Nkr8.48 Million ≈ $892.02K USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore net asset momentum of Lifecare AS to track the company's year-over-year net asset growth rate.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Nkr54.47 Million |
| % of Total Assets | 86.53% |
| Annual Growth Rate | N/A |
| 5-Year Change | -215.56% |
| 10-Year Change | -3402.12% |
| Growth Volatility | 138.79 |
Net Assets of Lifecare AS (2015–2025)
Net assets of Lifecare AS from 2015 to 2025. This chart illustrates how Lifecare AS's net assets have evolved over time, based on quarterly financial data. See LIFE equity financing ratio to measure how much of total assets are equity-financed.
Annual Net Assets for Lifecare AS (2015–2025)
The table below shows the annual net assets of Lifecare AS from 2015 to 2025. For live market cap and overall valuation, see how much is Lifecare AS worth.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | Nkr-28.02 Million ≈ $-2.95 Million |
-137.87% |
| 2024-12-31 | Nkr73.98 Million ≈ $7.78 Million |
+11.32% |
| 2023-12-31 | Nkr66.45 Million ≈ $6.99 Million |
+20.28% |
| 2022-12-31 | Nkr55.25 Million ≈ $5.81 Million |
+127.88% |
| 2021-12-31 | Nkr24.25 Million ≈ $2.55 Million |
+81.94% |
| 2020-12-31 | Nkr13.33 Million ≈ $1.40 Million |
-15.30% |
| 2019-12-31 | Nkr15.73 Million ≈ $1.66 Million |
-29.26% |
| 2018-12-31 | Nkr22.24 Million ≈ $2.34 Million |
+1045.89% |
| 2017-12-31 | Nkr-2.35 Million ≈ $-247.41K |
-377.11% |
| 2016-12-31 | Nkr848.46K ≈ $89.28K |
-49.65% |
| 2015-12-31 | Nkr1.69 Million ≈ $177.32K |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Lifecare AS's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 2277114400.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Lifecare AS Net Assets Breakdown (December 2025)
Lifecare AS net assets breakdown by equity component as of December 2025.
| Component | Amount | Percentage |
|---|---|---|
| Other Components | Nkr10.33 Million | % |
| Total Equity | Nkr-27.22 Million | 100.00% |
Lifecare AS Competitors by Market Cap
The table below lists competitors of Lifecare AS ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Crunchfish AB
ST:CFISH
|
$17.84 Million |
|
Quartz Mountain Resources Ltd
V:QZM
|
$17.84 Million |
|
BMG Resources Ltd
AU:BMG
|
$17.85 Million |
|
Les Enphants Co Ltd
TW:2911
|
$17.85 Million |
|
Alphawave IP Group PLC
LSE:AWE
|
$17.82 Million |
|
Thai Nondestructive Testing Public Company Limited
BK:TNDT
|
$17.81 Million |
|
Leeuwin Metals Ltd
AU:LM1
|
$17.81 Million |
|
Aqua Corporation Public Company Limited
BK:AQUA
|
$17.81 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Lifecare AS's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 74,410,000 to -27,222,000, a change of -101,632,000 (-136.6%).
- Net loss of 119,513,000 reduced equity.
- New share issuances of 17,056,000 increased equity.
- Other comprehensive income decreased equity by 1,000.
- Other factors increased equity by 826,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Nkr-119.51 Million | -439.03% |
| Share Issuances | Nkr17.06 Million | +62.66% |
| Other Comprehensive Income | Nkr-1.00K | -0.0% |
| Other Changes | Nkr826.00K | +3.03% |
| Total Change | Nkr- | -136.58% |
Book Value vs Market Value Analysis
This analysis compares Lifecare AS's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2015-12-31 | Nkr0.30 | Nkr0.42 | x |
| 2016-12-31 | Nkr0.15 | Nkr0.42 | x |
| 2017-12-31 | Nkr-0.42 | Nkr0.42 | x |
| 2018-12-31 | Nkr2.75 | Nkr0.42 | x |
| 2019-12-31 | Nkr1.94 | Nkr0.42 | x |
| 2020-12-31 | Nkr1.48 | Nkr0.42 | x |
| 2021-12-31 | Nkr2.70 | Nkr0.42 | x |
| 2022-12-31 | Nkr4.79 | Nkr0.42 | x |
| 2023-12-31 | Nkr7.17 | Nkr0.42 | x |
| 2024-12-31 | Nkr5.83 | Nkr0.42 | x |
| 2025-12-31 | Nkr-0.50 | Nkr0.42 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Lifecare AS utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -106708.04%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-125.55%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2015 | -444.70% | -192.44% | 1.71x | 1.35x | Nkr-7.66 Million |
| 2016 | -588.64% | -309.46% | 0.87x | 2.19x | Nkr-5.08 Million |
| 2017 | 0.00% | -622.56% | 0.46x | 0.00x | Nkr-3.20 Million |
| 2018 | -39.54% | -252.25% | 0.15x | 1.05x | Nkr-11.02 Million |
| 2019 | -41.67% | -316.87% | 0.12x | 1.11x | Nkr-8.13 Million |
| 2020 | -20.57% | -163.88% | 0.11x | 1.10x | Nkr-4.07 Million |
| 2021 | -65.48% | -4894.06% | 0.01x | 1.33x | Nkr-18.30 Million |
| 2022 | -30.97% | -104.56% | 0.24x | 1.24x | Nkr-23.12 Million |
| 2023 | -53.10% | -269.43% | 0.15x | 1.30x | Nkr-41.90 Million |
| 2024 | -96.43% | -2367.44% | 0.03x | 1.51x | Nkr-79.20 Million |
| 2025 | 0.00% | -106708.04% | 0.00x | 0.00x | Nkr-116.79 Million |
Industry Comparison
This section compares Lifecare AS's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $89,052,003
- Average return on equity (ROE) among peers: -43.04%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Lifecare AS (LIFE) | Nkr54.47 Million | -444.70% | 0.16x | $17.83 Million |
| Gentian Diagnostics AS (GENT) | $194.05 Million | 23.34% | 0.18x | $64.27 Million |
| Medistim ASA (MEDI) | $61.71 Million | 0.00% | 0.20x | $601.85 Million |
| Observe Medical Asa (OBSRV) | $11.39 Million | -152.45% | 4.62x | $12.09 Million |
About Lifecare AS
Lifecare ASA, together with its subsidiaries, operates as a medical sensor company that develops technology for sensing and monitoring of various body analytes in Norway and United Kingdom. The company develops Sencell, a 3D printed nano-sensor for monitoring glucose levels in patients with diabetes and for veterinary applications; as well as medical devices that remove subdermal implants. Lifeca… Read more